Human corneal microRNA expression profile in fungal keratitis

Investigative Ophthalmology and Visual Science

Volumn 56, Issue 13, 2015, Pages 7939-7946

  Boomiraj, Hemadevi ^a   Mohankumar, Vidyarani ^a   Lalitha, Prajna ^a   Devarajan, Bharanidharan ^a  

^a ARAVIND MEDICAL RESEARCH FOUNDATION   (India)

Author keywords

Deep sequencing; Keratitis; MicroRNA; MIF; Wound inflammation

Indexed keywords

CD59 ANTIGEN; CHEMOKINE RECEPTOR CXCR2; CHEMOKINE RECEPTOR CXCR4; CUTANEOUS T CELL ATTRACTING CHEMOKINE; CYCLIN DEPENDENT KINASE 6; EARLY GROWTH RESPONSE FACTOR 3; FAS LIGAND; MACROPHAGE MIGRATION INHIBITION FACTOR; MICRORNA; MICRORNA 124 3P; MICRORNA 142 3P; MICRORNA 142 5P; MICRORNA 144 3P; MICRORNA 144 5P; MICRORNA 146B 5P; MICRORNA 155 5P; MICRORNA 184; MICRORNA 204 5P; MICRORNA 21 5P; MICRORNA 223 3P; MICRORNA 451A; MICRORNA 511 5P; MICRORNA 618; MITOGEN ACTIVATED PROTEIN KINASE 1; MYELOID DIFFERENTIATION FACTOR 88; RAC1 PROTEIN; STAT3 PROTEIN; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ADULT; ARTICLE; ASPERGILLUS FLAVUS; BIOINFORMATICS; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE CONTROL; HUMAN; HUMAN TISSUE; KERATOMYCOSIS; MALE; MIDDLE AGED; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RNA EXTRACTION; RNA SEQUENCE; AGED; ASPERGILLOSIS; CORNEA; FUNGAL EYE INFECTION; GENE EXPRESSION PROFILING; GENETICS; ISOLATION AND PURIFICATION; KERATITIS; METABOLISM; PHYSIOLOGY; PROCEDURES; SEQUENCE ANALYSIS; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ASPERGILLOSIS; ASPERGILLUS FLAVUS; CORNEA; EYE INFECTIONS, FUNGAL; FEMALE; GENE EXPRESSION PROFILING; HUMANS; KERATITIS; MALE; MICRORNAS; MIDDLE AGED; REAL-TIME POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, RNA;

EID: 84950335899     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.15-17619     Document Type: Article

References (54)

1. Whitcher JP, Srinivasan M, Upadhyay MP. Corneal blindness: a global perspective. Bull World Health Organ. 2001;79:214-221.
2. National Survey on Blindness. 1991-2001. Report 2002. New Delhi, India: Ministry of Health and Family Welfare, 2002.
3. Garg P, Rao GN. Corneal ulcer: diagnosis and management. Community Eye Health. 1999;12:21-23.
4. Thomas PA. Fungal infections of the cornea. Eye. 2003;17: 852-862.
5. Srinivasan M. Fungal keratitis. Curr Opin Ophthalmol. 2004; 15:321-327.
6. Vemuganti GK, Garg P, Gopinathan U, et al. Evaluation of agent and host factors in progression of mycotic keratitis: a histologic and microbiologic study of 167 corneal buttons. Ophthalmology. 2002;109:1538-1546.
7. Valinezhad Orang A, Safaralizadeh R, Kazemzadeh-Bavili M. Mechanisms of miRNA-mediated gene regulation from common downregulation to mRNA-specific upregulation. Int J Genomics. 2014;2014:970607.
8. Karali M, Peluso I, Gennarino VA, et al. miRNeye: a microRNA expression atlas of the mouse eye. BMC Genomics. 2010;11: 715.
9. Tanaka Y, Tsuda S, Kunikata H, et al. Profiles of extracellular miRNAs in the aqueous humor of glaucoma patients assessed with a microarray system. Sci Rep. 2014;4:5089.
10. Hughes AE, Bradley DT, Campbell M, et al. Mutation altering the miR-184 seed region causes familial keratoconus with cataract. Am J Hum Genet. 2011;89:628-633.
11. Matthaei M, Hu J, Kallay L, et al. Endothelial cell microRNA expression in human late-onset Fuchs’ dystrophy. Invest Ophthalmol Vis Sci. 2014;55:216-225.
12. Mulik S, Bhela S, Rouse BT. Potential function of miRNAs in herpetic stromal keratitis. Invest Ophthalmol Vis Sci. 2013;54: 563-573.
13. van Rooij E, Kauppinen S. Development of microRNA therapeutics is coming of age. EMBO Mol Med. 2014;6:851-864.
14. Hassan T, McKiernan PJ, McElvaney NG, et al. Therapeutic modulation of miRNA for the treatment of proinflammatory lung diseases. Expert Rev Anti Infect Ther. 2012;10:359-368.
15. Ma X, Becker Buscaglia LE, Barker JR, Li Y. MicroRNAs in NF-kappaB signaling. J Mol Cell Biol. 2011;3:159-166.
16. He X, Jing Z, Cheng G. MicroRNAs: new regulators of Toll-like receptor signaling pathways. Biomed Res Int. 2014;2014: 945169.
17. Langmead B, Trapnell C, Pop M, Salzberg SL. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol. 2009;10:R25.
18. Barturen, G, Rueda, A, Hamberg, M, et al. sRNAbench: profiling of small RNAs and its sequence variants in single or multi-species high-throughput experiments. Methods Next Gener Seq. 2014;1:21-31.
19. Kozomara A, Griffiths-Jones S. miRBase: integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res. 2011;39:D152-D157.
20. Maragkakis M, Reczko M, Simossis VA, et al. DIANA-microT web server: elucidating microRNA functions through target prediction. Nucleic Acids Res. 2009;37:W273-W276.
21. Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell. 2005;120:15-20.
22. John B, Enright AJ, Aravin A, Tuschl T, Sander C, Marks DS. Human microRNA targets. PLoS Biol. 2004;2:e363.
23. Kertesz M, Iovino N, Unnerstall U, Gaul U, Segal E. The role of site accessibility in microRNA target recognition. Nat Genet. 2007;39:1278-1284.
24. Sethupathy P, Corda B, Hatzigeorgiou AG. TarBase: a compre-hensive database of experimentally supported animal micro-RNA targets. RNA. 2006;12:192-197.
25. Xiao F, Zuo Z, Cai G, Kang S, Gao X, Li T. miRecords: an integrated resource for microRNA-target interactions. Nucleic Acids Res. 2009;37:D105-D110.
26. Huang DW, Sherman BT, Lempicki RA. Bioinformatics enrich-ment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 2009;37:13.
27. Wei Y, Yang J, Yi L, et al. MiR-223-3p targeting SEPT6 promotes the biological behavior of prostate cancer. Sci Rep. 2014;4: 7546.
28. Roy S, Sen CK. miRNA in wound inflammation and angiogen-esis. Microcirculation. 2012;19:224-232.
29. Zhao X, Guan JL. Focal adhesion kinase and its signaling pathways in cell migration and angiogenesis. Adv Drug Deliv Rev. 2011;63:610-615.
30. You L, Kruse FE, Völcker HE. Neurotrophic factors in the human cornea. Invest Ophthalmol Vis Sci. 2000;41:692-702.
31. Maycock NJR, Marshall J. Genomics of corneal wound healing: a review of the literature. Acta Ophthalmol. 2014;92:e170-e184.
32. Tillmann S, Bernhagen J, Noels H. Arrest functions of the MIF ligand/receptor axes in atherogenesis. Front Immunol. 2013; 4:115.
33. Gilliver SC, Emmerson E, Bernhagen J, Hardman MJ. MIF: a key player in cutaneous biology and wound healing. Exp Dermatol. 2011;20:6.
34. Bernhagen J, Krohn R, Lue H, et al. MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogeniccell recruitment. Nat Med. 2007;13:587-596.
35. Dewor M, Steffens G, Krohn R, Weber C, Baron J, Bernhagen J. Macrophage migration inhibitory factor (MIF) promotes fibroblast migration in scratch-wounded monolayers in vitro. FEBS Lett. 2007;581:4734-4742.
36. Karthikeyan RS, Leal SM, Prajna NV, et al. Expression of innate and adaptive immune mediators in human corneal tissue infected with Aspergillus or fusarium. J Infect Dis. 2011;204: 942-950.
37. Baron VT, Pio R, Jia Z, Mercola D. Early growth response 3 regulates genes of inflammation and directly activates IL6 and IL8 expression in prostate cancer. Br J Cancer. 2015;112:755-764.
38. Leal SM, Pearlman E. The role of cytokines and pathogen recognition molecules in fungal keratitis - insights from human disease and animal models. Cytokine. 2012;58:107-111.
39. Funari VA, Winkler M, Brown J, Dimitrijevich SD, Ljubimov AV, Saghizadeh M. Differentially expressed wound healing-related microRNAs in the human diabetic cornea. PLoS One. 2013;8: e84425.
40. An J, Chen X, Chen W, et al. MicroRNA expression profile and the role of miR-204 in corneal wound healing. Invest Ophthalmol Vis Sci. 2015;56:3673.
41. Hamrah P, Huq SO, Liu Y, Zhang Q, Dana MR. Corneal immunity is mediated by heterogeneous population of antigen-presenting cells. J Leukoc Biol. 2003;74:172-178.
42. Allantaz F, Cheng DT, Bergauer T, et al. Expression profiling of human immune cell subsets identifies miRNA-mRNA regulatory relationships correlated with cell type specific expression. PLoS One. 2012;7:e29979.
43. Szczepankiewicz A, Lackie PM, Holloway JW. Altered micro-RNA expression profile during epithelial wound repair in bronchial epithelial cells. BMC Pulm Med. 2013;13:63.
44. Palazzo E, Marconi A, Truzzi F, et al. Role of neurotrophins on dermal fibroblast survival and differentiation. J Cell Physiol. 2012;227:1017-1025.
45. Bandres E, Bitarte N, Arias F, et al. microRNA-451 regulates macrophage migration inhibitory factor production and proliferation of gastrointestinal cancer cells. Clin Cancer Res. 2009;15:2281-2290.
46. Gadjeva M, Nagashima J, Zaidi T, Mitchell RA, Pier GB. Inhibition of macrophage migration inhibitory factor amelio-rates ocular Pseudomonas aeruginosa-induced keratitis. PLoS Pathog. 2010;6:e1000826.
47. Zhang C, Chi YL, Wang PY, et al. miR-511 and miR-1297 inhibit human lung adenocarcinoma cell proliferation by targeting oncogene TRIB2. PLoS One. 2012;7:e46090.
48. Zhang Z, Li Z, Li Y, Zang A. MicroRNA and signaling pathways in gastric cancer. Cancer Gene Ther. 2014;21:305-316.
49. Kästingschäfer CS, Schäfer SD, Kiesel L, Götte M. miR-142-3p is a novel regulator of cell viability and proinflammatory signalling in endometrial stroma cells. Reprod Biomed Online. 2015;30:553-556.
50. Cheng Q, Zhang X, Xu X, Lu X. MiR-618 inhibits anaplastic thyroid cancer by repressing XIAP in one ATC cell line. Ann Endocrinol (Paris). 2014;75:187-193.
51. Kee HJ, Park S, Kwon J-S, et al. B cell translocation gene, a direct target of miR-142-5p, inhibits vascular smooth muscle cell proliferation by down-regulating cell cycle progression. FEBS Lett. 2013;587:2385-2392.
52. Xu R, Bi C, Song J, et al. Upregulation of miR-142-5p in atherosclerotic plaques and regulation of oxidized low-density lipoprotein-induced apoptosis in macrophages. Mol Med Rep. 2015;11:3229-3234.
53. Hu Y-W, Hu Y-R, Zhao J-Y, et al. An agomir of miR-144-3p accelerates plaque formation through impairing reverse cholesterol transport and promoting pro-inflammatory cytokine production. PLoS One. 2014;9:e94997.
54. Matsushita R, Seki N, Chiyomaru T, et al. Tumour-suppressive microRNA-144-5p directly targets CCNE1/2 as potential prognostic markers in bladder cancer. Br J Cancer. 2015; 113:282-289.